Preferences of Physicians for Systemic Therapies in Atopic Dermatitis

Preferences of Physicians for Systemic Therapies in Atopic Dermatitis - AD-Prefer-Doc

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00035703

Enrollment

300

Registered

2024-12-16

Start date

2024-12-16

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L20

Interventions

Group 1: Physicians are responding to a conjoint analysis on preferences for systemic therapies.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Professional Role: Currently working as a board-certified dermatologist or as a resident in training in the specialty of dermatology and venereology. Clinical Experience: Experience in treating patients with atopic dermatitis, including at least one patient receiving systemic therapy. Informed Consent: Willingness to provide informed consent for participation in the study.

Exclusion criteria

Exclusion criteria: Insufficient language skills and incapacity to consent.

Design outcomes

Primary

Measure	Time frame
Determination of Physicians' Preferences for the Outcome and Process Attributes of Systemic Therapies in Atopic Dermatitis Using DCE.	—

Secondary

Measure	Time frame
The secondary study objective is to determine the influence of physician characteristics on these preferences.	—

Countries

Germany

Contacts

Public ContactMarthe-Lisa Schaarschmidt

Klinik für Dermatologie, Venerologie und Allergologie, Universitätsmedizin Mannheim

marthe-lisa.schaarschmidt@umm.de+496213832280

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026